A novel POLD1 pathogenic variant identified in two families with a cancer spectrum mimicking lynch syndrome.
Fiche publication
Date publication
décembre 2021
Journal
European journal of medical genetics
Auteurs
Membres identifiés du Cancéropôle Est :
Dr NAMBOT Sophie
Tous les auteurs :
Legrand C, Lebrun M, Naibo P, Peysselon M, Prieur F, Kientz C, Desseigne F, Handallou S, Rey JM, Nambot S, Goussot V, Hamzaoui N, Wang Q
Lien Pubmed
Résumé
The POLD1 gene is involved in DNA proofreading to ensure accurate DNA replication. Some germline alterations in its exonuclease domain are associated with predisposition to cancers and colonic polyps. Only a few pathogenic variants have been clearly identified so far. Here we report a novel variant: c.1458G > T p.(Lys486Asn) that we classified as pathogenic, detected in two putatively unrelated families. The cancer spectrum was very similar to Lynch syndrome, implying an overlapped tissue susceptibility. The common presence of colonic polyps in carriers and the MMR proficient phenotype in tumors were distinctive features suggesting POLD1 implication. Some clinical characteristics observed in the carriers of this variant differed from those reported previously, suggesting a potential genotype/phenotype correlation, and very likely in relation to the functional importance of affected residues. Our findings provide further insight into understanding the role of POLD1 in cancer-related risk.
Mots clés
Cancer predisposition, Hereditary colorectal cancer, Lynch syndrome, POLD1 gene, PPAP syndrome
Référence
Eur J Med Genet. 2021 Dec 22;:104409